lobbying_filings_raw: 085941b9-a3d3-46da-b778-e1bb0df09022

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
085941b9-a3d3-46da-b778-e1bb0df09022 Q4 321874 VAN HEUVELEN STRATEGIES, LLC 186909 GENERIC PHARMACEUTICAL ASSOCIATION 2012 fourth_quarter 2013-01-11T15:36:28.543000-05:00 80000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/085941b9-a3d3-46da-b778-e1bb0df09022/", "filing_uuid": "085941b9-a3d3-46da-b778-e1bb0df09022", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2012, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/085941b9-a3d3-46da-b778-e1bb0df09022/print/", "filing_document_content_type": "text/html", "income": "80000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Robert Van Heuvelen, Principal", "dt_posted": "2013-01-11T15:36:28.543000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "300 NEW JERSEY AVENUE, NW", "registrant_address_2": "SUITE 601", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 321874, "url": "https://lda.senate.gov/api/v1/registrants/321874/", "house_registrant_id": 39614, "name": "VAN HEUVELEN STRATEGIES, LLC", "description": "â\u20ac\u2039Strategic consulting and lobbying", "address_1": "440 1st St, NW", "address_2": "SUITE 440", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ROBERT VAN HEUVELEN", "contact_telephone": "", "dt_updated": "2022-04-06T16:08:35.515010-04:00"}, "client": {"id": 186909, "url": "https://lda.senate.gov/api/v1/clients/186909/", "client_id": 520, "name": "GENERIC PHARMACEUTICAL ASSOCIATION", "general_description": "Membership org. representing manufacturers and distributors of generic pharmaceuticals.", "client_government_entity": false, "client_self_select": false, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2012-02-28"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Prescription drug user fee act and other issues related to generic drugs; Generic Drug User Fee Act, S.3187 Food and Drug Administration Safety and Innovation Act; S.2295 the Patient Safety and Generic Labeling Improvement Act, issues related to patent settlements; H.R.6433, FDA User Fee Corrections Act of 2012.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 36335, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": null, "last_name": "VAN HEUVELEN", "suffix": null, "suffix_display": null}, "covered_position": "Chief of Staff to Senator Kent Conrad", "new": false}, {"lobbyist": {"id": 55136, "prefix": null, "prefix_display": null, "first_name": "DIANE", "nickname": null, "middle_name": null, "last_name": "MAJOR", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Assistant, Congressman Craig Thomas", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "Prescription drug user fee act and other issues related to generic drugs; Generic Drug User Fee Act, S.3187 Food and Drug Administration Safety and Innovation Act, S.2295 the Patient Safety and Generic Labeling Improvement Act, issues related to patent settlements; H.R.6433, FDA User Fee Corrections Act of 2012.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 36335, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": null, "last_name": "VAN HEUVELEN", "suffix": null, "suffix_display": null}, "covered_position": "Chief of Staff to Senator Kent Conrad", "new": false}, {"lobbyist": {"id": 55136, "prefix": null, "prefix_display": null, "first_name": "DIANE", "nickname": null, "middle_name": null, "last_name": "MAJOR", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Assistant, Congressman Craig Thomas", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 39614 DC   US US Membership org. representing manufacturers and distributors of generic pharmaceuticals. 0 0        

Links from other tables